当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第9期
编号:12766731
载脂蛋白E基因多态性与血脂代谢及脂蛋白肾病(3)
http://www.100md.com 2016年3月5日 医学信息 2016年第9期
     [7]Mahley,R.W.,K.H.Weisgraber,and Y.Huang,Apolipoprotein E:structure determines function,from atherosclerosis to Alzheimer's disease to AIDS[J].J Lipid Res,2009,50(Suppl):S183-188.

    [8]Saito,T.Lipoprotein glomerulopathy:glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia[J].Am J Kidney Dis,1989,13(2):148-153.

    [9]Hoffmann,M.Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy[J].J Am Soc Nephrol,2001,12(3):524-530.

    [10]Sam,R..Lipoprotein glomerulopathy:a new apolipoprotein E mutation with enhanced glomerular binding[J].Am J Kidney Dis,2006,47(3):539-548.

    [11]Zhang,B.Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy[J].J Nephrol,2008,21(1):110.

    [12]Ricardo,S.D.,H.van Goor,and J.R.Diamond,Hypercholesterolemia and progressive kidney disease:the role of macrophages and macrophage-derived products[J].Contrib Nephrol,1997,120:197-209.

    [13]Xin,Z.Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption:a pilot study[J].Nephrol Dial Transplant,2009,24(3):864-869.

    [14]Chen,H.K..Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons[J].J Biol Chem,2012,287(8):5253-5266.编辑/丁一, http://www.100md.com(樊明智 郑洁 周建中)
上一页1 2 3